This combination has “the potential to become a new standard first-line treatment” for well-differentiated grade 1/2 gastroenteropancreatic neuroendocrine tumors with poor prognostic factors ...
“Treating neuroendocrine tumors after disease progression can be ... The most common primary tumor locations were ileum/cecum (54%), small intestine with location not specified (20%), non ...
Background. A 48-year-old man presented with diarrhea, flushing, abdominal pain and weight loss of 10 kg over a 6-month period. He subsequently developed dyspnea on exertion. Diagnosis. Carcinoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback